Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX
Recorded on February 18, 2022
Srdan Verstovsek, MD, PhD
Professor of Medicine
Director, Hanns A. Pielenz Clinical Research Center
for Myeloproliferative Neoplasms
Department of Leukemia
MD Anderson Cancer Center
Houston, TX
Professor of Medicine
Director, Hanns A. Pielenz Clinical Research Center
for Myeloproliferative Neoplasms
Department of Leukemia
MD Anderson Cancer Center
Houston, TX
In this month’s episode, Dr. Srdan Verstovsek, from MD Anderson Cancer Center in Houston, Texas, joins us to discuss myelofibrosis. What is myelofibrosis? What is our understanding of the disease? What are the deciding factors for cells to branch off into myelofibrosis and not other myeloproliferative neoplasms? Tune in as we explore myelofibrosis, including discussion on diagnosing and staging, goals and considerations for therapy, the impact of COVID-19 on treatment, and new and emerging drugs in development.
Podcast: Play in new window | Download (Duration: 38:04 — 34.9MB)
This podcast episode is supported by AbbVie Inc.